Novo Nordisk offers a unique GARP investment opportunity, with strong growth catalysts and attractive valuation. Read here ...

Constipation is a common but manageable side effect of Ozempic, a medication for diabetes and weight loss. It often occurs in ...

Some research suggests supplements such as berberine, curcumin, resveratrol, fish oil, and probiotics may boost your body's ...

Novo Nordisk (NVO) is deeply undervalued after a 43% YTD decline, despite strong fundamentals and global obesity market ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

Three new Cochrane reviews find evidence that GLP-1 drugs result in clinically meaningful weight loss, but industry-funded studies raise questions. The reviews were commissioned by the World Health ...

Approximately one in eight Americans has taken a GLP-1 or glucagon-like peptide-1 receptor agonist. These medications were originally developed to help manage type 2 diabetes, but they also support ...

If your patients are taking GLP-1s, you’ve explained the common side effects, such as gastrointestinal (GI) issues and muscle-loss implications. However, GLP-1 receptor agonists, often prescribed for ...

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...

New research reveals that popular GLP-1 medications like Ozempic could change how quickly alcohol affects the body, offering early clues into their surprising impact on craving, intoxication, and ...

A new study suggests GLP-1 drugs like Ozempic and Wegovy — commonly used for diabetes and weight loss — may also blunt the effects of alcohol. That might be bad news for casual drinkers, but ...